Journal of clinical psychopharmacology

publication venue for

Reinduction of neuroleptic malignant syndrome by lithium. 1987
Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics. 1985
Peripheral edema associated with trazodone: a report of ten cases. 1985
Nortriptyline capacity-limited metabolism: a case report. 1984
Psychiatric reactions during tricyclic treatment of the elderly reconsidered. 1983
Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy.. 41. 2021
Characterization of the Safety and Pharmacokinetic Profile of D-Methadone, a Novel N-Methyl-D-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects: Results of Two Phase 1 Studies.. 39. 2019
Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.. 37. 2017
Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination.. 37. 2017
An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.. 36. 2016
Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study.. 35. 2015
The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.. 33. 2013
Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study.. 32. 2012
Lithium-induced renal insufficiency: a longitudinal study of creatinine increases in intellectually disabled adults.. 31. 2011
Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.. 31. 2011
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.. 30. 2010
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.. 29. 2009
The efficacy of divalproex sodium in the treatment of agitation associated with major depression.. 25. 2005
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.. 24. 2004
A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.. 23. 2003
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.. 22. 2002
Rapid reversal of psychotic depression using mifepristone.. 21. 2001
Predicting response to fluoxetine in geriatric patients with major depression.. 15. 1995
Predictors of response to desipramine in dysthymia.. 15. 1995
Rash complicating carbamazepine treatment.. 14. 1994
Nefazodone in the treatment of premenstrual syndrome: a preliminary study.. 14. 1994
Fluoxetine and desipramine in major depressive disorder.. 13. 1993
Neuropsychologic effects of lithium discontinuation.. 13. 1993
Nortriptyline and weight change in depressed patients over 60.. 12. 1992
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.. 11. 1991
Amoxapine versus amitriptyline for continuation therapy of depression.. 10. 1990
Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives.. 4. 1984
Age as a predictor of treatment response in endogenous depression.. 3. 1983
The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.. 2. 1982
Exploring Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Extinction Learning-Based Treatment Outcome in Obsessive-Compulsive Disorder: A Pilot Study. 2019
Supatherapeutic Serum Clozapine Concentration After Transition From Traditional to Electronic Cigarettes. 2018
Bupropion XL for the sustained treatment of trichotillomania. 2012
Memantine for posttraumatic stress disorder in an older veteran. 2011
Adding aripiprazole to clozapine worsened delusions and hallucinations: a case report. 2011
Minimum effective and relapse-associated doses of risperidone and olanzapine in aggressive, intellectually disabled adults. 2011
Antidepressant-induced sweating alleviated by aripiprazole. 2008
A case of hyponatremia induced by duloxetine. 2006
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. 2000
Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia. 1992
Theoretical basis for response to steroid suppression in major depression. 1992
Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome. 1991
Dexamethasone suppression test. 1982
Behavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment.. 36. 2016
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis. 2022
The efficacy of antidepressants in the treatment of late-life depression. 2005
The pharmacologic treatment of neuroleptic-induced akathisia. 1990
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine. 1987
Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis. 1983

VIVO Weill Cornell Medical College

Journal of clinical psychopharmacology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)